NCT00570687View on ClinicalTrials.gov

A Study Comparing Subcutaneous Rapid Acting Insulin and One Formulation of Inhaled Insulin in Subjects With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Technosphere Insulin

Inhalation 15U/30U

Trial Locations (1)

Unknown

Profil Institute for Metabolic Research, Neuss

Sponsors
All Listed Sponsors
lead

Mannkind Corporation

INDUSTRY